The HCS1 Antibody (also called mAb76) is a mouse-derived monoclonal IgG2a antibody that specifically targets otoferlin, a calcium-binding protein critical for synaptic vesicle exocytosis in auditory hair cells . Otoferlin mutations are linked to DFNB9, a form of prelingual deafness, making this antibody a vital tool for studying auditory neuropathies .
Generation: Produced via hybridoma technology using delaminated chick utricles as immunogens .
Specificity: Recognizes otoferlin across vertebrates, including mammals, birds, fish, and amphibians .
Biochemical Properties:
Distribution: Otoferlin localizes to the basolateral membrane and cytoplasmic vesicles of hair cells, suggesting roles beyond synaptic transmission (e.g., membrane repair or trafficking) .
Co-Localization Studies: Does not overlap with ribeye (synaptic ribbon marker), indicating distinct functional pathways .
Auditory Neuropathy: Otoferlin’s role in vesicle fusion explains its association with DFNB9, characterized by impaired sound signal transmission .
Biochemical Stability: Otoferlin’s membrane affinity and resistance to solubilization suggest structural resilience in hair cells .
Chick and Guinea Pig: Strong immunolabeling in inner ear hair cells, validating cross-species utility .
Fish and Amphibians: Conservation of otoferlin expression highlights evolutionary importance in mechanosensory function .
The HCS-1 antibody is a mouse monoclonal antibody (isotype IgG2a) that specifically targets otoferlin, also known as Hair cell soma-1 or Fer-1-like protein 2. This protein functions as a key calcium ion sensor regulating neurotransmitter release in sensory systems. The antibody was developed using delaminated chick utricles emulsion as the immunogen and recognizes a protein with a molecular weight of approximately 210-230 kDa .
HCS-1 antibody demonstrates exceptionally broad cross-species reactivity, making it valuable for comparative studies. It has been confirmed to react with samples from Amphibian, Avian, Elasmobranch, Fish, Mammal, and Reptile species . This extensive cross-reactivity makes it a versatile tool for evolutionary and comparative studies of otoferlin across diverse taxonomic groups.
Based on validation data, HCS-1 antibody is recommended for the following applications:
These applications make it suitable for localization studies, protein-protein interaction analyses, and examination of otoferlin expression in various tissue preparations.
For optimal performance, HCS-1 antibody should be stored according to these guidelines:
Short-term use (up to two weeks): Store at 4°C
Long-term storage: Divide into aliquots of no less than 20 μl and freeze at -20°C or -80°C
Avoid repeated freeze-thaw cycles as these can degrade antibody quality
Note that the antibody contains the antimicrobial ProClin as a preservative
Researchers can employ HCS-1 antibody to:
Visualize the spatial distribution of otoferlin in hair cells across different species
Investigate co-localization with other synaptic proteins involved in exocytosis
Study alterations in otoferlin localization in models of hearing impairment
Examine calcium-dependent trafficking of otoferlin during stimulation
Methodologically, this can be combined with calcium imaging techniques to correlate otoferlin distribution with calcium influx patterns during synaptic activity, providing insights into the molecular machinery of sensory transduction.
For optimal results in immunohistochemistry using HCS-1 antibody:
Fixation: Use 4% paraformaldehyde for 2-4 hours at 4°C for whole tissues; shorter times (15-20 minutes) for cell cultures
For inner ear tissues: Consider gentle decalcification with EDTA after fixation
Cryoprotection: Immerse in 30% sucrose solution before embedding
Sectioning: Prepare 10-15 μm cryosections for optimal antibody penetration
Antigen retrieval: Mild heat-induced epitope retrieval may enhance signal
Blocking: Use 5-10% normal serum with 0.1-0.3% Triton X-100 to reduce background
| Issue | Potential Causes | Troubleshooting Strategies |
|---|---|---|
| Weak signal | Insufficient antibody concentration | Titrate antibody concentration (try 1:500, 1:200, 1:100) |
| Poor epitope accessibility | Optimize antigen retrieval methods | |
| Excessive washing | Reduce washing stringency | |
| Degraded antibody | Use fresh aliquot, avoid repeated freeze-thaw | |
| High background | Insufficient blocking | Increase blocking time and concentration |
| Non-specific binding | Add 0.1-0.3% Triton X-100 to blocking solution | |
| Cross-reactivity | Pre-absorb antibody with non-specific proteins | |
| Overfixation | Reduce fixation time or concentration |
When conducting cross-species studies with HCS-1:
Optimize antibody concentration for each species separately
Adjust fixation protocols to account for tissue structure differences
Include positive controls from well-characterized species
Verify correct molecular weight via Western blot for each species
Consider evolutionary conservation of the epitope region
Normalize signal intensities when making quantitative comparisons
A robust experimental design using HCS-1 antibody should include:
Positive control: Tissue known to express otoferlin (e.g., cochlear hair cells)
Negative control: Tissue where otoferlin is not expressed
Primary antibody omission control: To assess secondary antibody specificity
Isotype control: Using an irrelevant mouse IgG2a at the same concentration
Concentration gradient: Testing different antibody dilutions to determine optimal signal-to-noise ratio
If available, tissue from otoferlin knockout models as a specificity control
HCS-1 antibody can be strategically employed in hearing and balance disorder research:
Compare otoferlin distribution between normal and pathological samples
Quantify otoferlin levels in models of genetic hearing loss
Investigate the effects of ototoxic compounds on otoferlin expression
Study the relationship between otoferlin distribution and functional hearing metrics
Examine changes in otoferlin localization during hair cell development or regeneration
Methodologically, researchers should combine immunolabeling with functional assessments (e.g., auditory brainstem responses) to correlate molecular findings with physiological outcomes.
For effective co-localization studies:
Select compatible secondary antibodies with non-overlapping emission spectra
If using multiple mouse antibodies, employ sequential staining with appropriate blocking steps
Use confocal or super-resolution microscopy for precise spatial analysis
Apply quantitative co-localization analysis (Pearson's or Manders' coefficients)
Consider proximity ligation assays for direct protein-protein interaction analysis
Include appropriate controls to rule out spectral bleed-through
Quantitative analysis of HCS-1 immunolabeling can follow these methodologies:
Intensity measurements:
Define consistent regions of interest across samples
Normalize to internal controls
Use z-stack acquisition for volumetric analysis
Subcellular distribution analysis:
Perform line-scan analysis across cellular compartments
Calculate distance from reference structures (nucleus, membrane, synaptic ribbons)
Quantify apical vs. basolateral distribution ratios
Statistical approaches:
Compare means across multiple samples using appropriate statistical tests
Account for biological and technical replicates
Consider non-parametric tests for intensity data that may not be normally distributed
When interpreting results from HCS-1 immunolabeling, researchers should consider:
Epitope masking: Post-translational modifications or protein interactions may obscure the epitope
Fixation artifacts: Different fixation methods may alter apparent protein distribution
Detection threshold limitations: Low levels of expression may be below detection limits
Potential cross-reactivity with other ferlin family proteins due to sequence homology
Variability between antibody lots: Consider validating new lots against previous results
When correlating HCS-1 immunolabeling with functional data:
Consider that changes in otoferlin distribution may precede functional deficits
Interpret subcellular relocalization as potentially significant even without expression level changes
Recognize that immunofluorescence provides spatial information but limited quantitative data on protein activity
Complement imaging with physiological recordings of exocytosis (e.g., capacitance measurements)
Consider the impact of calcium concentration on otoferlin conformation and potential epitope accessibility
Researchers can implement HCS-1 antibody in drug discovery workflows by:
Developing automated immunofluorescence protocols for screening compound libraries
Establishing quantitative metrics for otoferlin expression and localization
Creating stable cell lines expressing otoferlin for consistent screening platforms
Combining with functional assays to correlate molecular and physiological effects
Implementing machine learning algorithms for pattern recognition in immunofluorescence images
Multimodal approaches incorporating HCS-1 antibody include:
Correlative light and electron microscopy (CLEM) to connect ultrastructure with protein localization
Combined electrophysiology and immunocytochemistry to link function with protein distribution
Live cell imaging followed by fixation and immunolabeling for dynamic-to-static correlation
RNA-scope in situ hybridization with immunohistochemistry to connect transcript and protein levels
Mass spectrometry following immunoprecipitation to identify otoferlin-interacting proteins